Common Sense for Drug Policy - Link to home page


Friday, June 23, 2017
Search using CSDP's own search tool or use
Google

WWW Common Sense


Home page

About CSDP

PSA Campaign


Check out these other CSDP news pages:
Afghanistan
AIDS
Anti-Drug Media Campaign
Asia and the US Drug War
Bolivia
Bush's Cabinet
Burma
Canada
Chronic Pain Management
Colombia
Communities Against the Drug War
Conferences & Events
Corruption
DARE Admits Failure
Drug Control Alternatives
Ecstasy
Families Targeted by Drug War
Federal Drug Control Strategy
Hemp News
Heroin & Heroin Addiction Treatment
Higher Education Act (HEA) Reform
Initiatives
International Reform
Laos
Mandatory Minimums
Marijuana
Medical Marijuana
Methamphetamines
Mexico
Narco-Funded Terrorism
New Mexico
Nixon
New York
ONDCP
OxyContin
Pain Management
Peru
Police Shootings & Botched Raids
Prop 36
Racial Profiling
Recommended Reading
Research News
South America
Thailand
Treatment Alternatives to Incarceration
Tulia
United Kingdom Moves Toward Reform
United Nations: News and Reports


Drug War Facts

Research Archive

Coalition for Medical Marijuana

Managing Chronic Pain

Drug War Distortions

Safety First

Get Active!

Drug Truth Network

Links

Drug Strategy

Drugs and Terror

Recommended Reading

Site Map



link to 
Drug War Facts - page opens in new window
Addict 
in the Family

Online Drug Library

Research Resources

Contact Common Sense



CSDP Blog



FDA Considers Banning Popular Prescription Pain Medications and Putting New Dose Restrictions on Over-the-Counter, Acetaminophen-Containing Drugs

As CNN reported on June 30, 2009 ("FDA Advisors Vote to Take Vicodin, Percocet Off Market"), an FDA advisory panel voted in favor of "eliminating prescription drugs that combine acetaminophin with narcotics -- such as Vicodin and Percocet -- because of their risks for overdose and severe liver injury." The panel also "advised the FDA to lower the maximum daily dose of acetaminophen in over-the-counter and prescription medications, and to address the formulations and dosing recommendations for children." Among other recommendations, the panel suggested that, if the FDA chooses not to remove the aforementioned medicines from pharmacy shelves, it could "lower the amount of acetaminophen" in drugs that combine acetaminophin and narcotic painkillers and "take some action to ensure that subscribers and patients are aware of the potential liver damage posed by taking these products." Although it typically follows advisory committee recommendations, CNN informs readers that it "is not required" to do so.

However, as Ohio newspaper the Columbus Dispatch reported on July 20, "Confusion and concern have followed news that the [FDA] is considering" the changes discussed above ("FDA Inquiry into Painkiller Perplexes Patients"). Interviews with local doctors confirm that patients should, as one physician stated, "talk to their doctors while the FDA decides what to do." However, "Many patients are nervous that tried and true drugs might go off the market, leaving them struggling to manage pain." The physicians who spoke with the Dispatch stressed that patients should not worry excessively but rather "take acetaminophen seriously, read labels, and understand that it's fine as long as it's not taken in excess." Moreover, the Dispatch's sources reached the consensus that "it would be a mistake to take Vicodin and Percocet off the market."

Sources at the FDA stated that "Changing dosing regulations on Tylenol would take years [...], and the agency is well aware of the concerns of people who rely on Percocet and Vicodin." FDA spokesperson Karen Riley suggested that "this will be a measured response [...], adding that labeling changes would be an option that could happen relatively quickly."

Back to top

Save This Page to del.icio.us

Home Drug War Facts Public Service
Advertisements
Managing Chronic Pain
Get Active About Common Sense Addict In
The Family
Effective Drug
Control Strategy
Drug War Distortions Recommended
Reading

copyright © 2000-2007, Common Sense for Drug Policy
Kevin B. Zeese, President -- Mike Gray, Chairman -- Robert E. Field, Co-Chairman -- Melvin R. Allen, Board Member -- Doug McVay, Director of Research & Editor
1377-C Spencer Ave., Lancaster, PA 17603
tel 717-299-0600 - fax 717-393-4953
Updated: Monday, July 20, 2009   ~   Accessed: 18218 times
Email us